Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
KLF5 encodes a member of the Kruppel-like factor subfamily of zinc finger proteins. Additionally we are shipping KLF5 Kits (7) and KLF5 Proteins (5) and many more products for this protein.
Showing 10 out of 70 products:
Human Polyclonal KLF5 Primary Antibody for IF (p), IHC (p) - ABIN739515
Zhang, Ha, Larouche, Swanson, Goldowitz: Kruppel-Like Factor 4 Regulates Granule Cell Pax6 Expression and Cell Proliferation in Early Cerebellar Development. in PLoS ONE 2015
Human Polyclonal KLF5 Primary Antibody for ICC, IF - ABIN4329154
Chen, Lin, Tang: Matrix-Stiffness-Regulated Inverse Expression of Krüppel-Like Factor 5 and Krüppel-Like Factor 4 in the Pathogenesis of Renal Fibrosis. in The American journal of pathology 2015
Human Polyclonal KLF5 Primary Antibody for FACS, IF - ABIN391515
Guo, Dong, Zhang, Zhao, Sun, Li, Dong: Pro-proliferative factor KLF5 becomes anti-proliferative in epithelial homeostasis upon signaling-mediated modification. in The Journal of biological chemistry 2009
Show all 2 Pubmed References
lf5 ChIP-seq revealed that Klf5 binding overlaps that of MyoD (show MYOD1 Antibodies) and Mef2 (show MEF2C Antibodies), and Klf5 physically associates with both MyoD (show MYOD1 Antibodies) and Mef2 (show MEF2C Antibodies). In addition, MyoD (show MYOD1 Antibodies) recruitment was greatly reduced in the absence of Klf5. These results indicate that Klf5 is an essential regulator of skeletal muscle differentiation, acting in concert with myogenic transcription factors such as MyoD (show MYOD1 Antibodies) and Mef2 (show MEF2C Antibodies).
KLF5 regulates intestinal barrier function by mediating the transcription of DSG2 (show DSG2 Antibodies), a gene encoding a major component of desmosome structures
Klf5 suppresses Fgf4 (show FGF4 Antibodies)-Fgfr (show FGFR2 Antibodies)-ERK (show EPHB2 Antibodies) signalling, thus preventing precocious activation of the primitive endoderm specification programme
In conclusion, the results of this study suggest that the presence of KLF5 in postn (show POSTN Antibodies)-positive cells contributes to the pathogenesis of aortic thickening induced by DOCA-salt hypertension.
these studies demonstrate dual functions of Klf5 in regulating hematopoietic stem and progenitor proliferation and localization in the bone marrow, as well as lineage choice after GMP (show NT5C2 Antibodies), promoting increased neutrophil output at the expense of eosinophil production.
Collectively, we identify a novel regulatory pathway in which 1, 25(OH)2D3 induces VDR (show CYP27B1 Antibodies) expression and promotes VDR (show CYP27B1 Antibodies) interaction with p50 subunit of NF-kappaB (show NFKB1 Antibodies), which in turn attenuates the association of KLF5 with p50 subunit of NF-kappaB (show NFKB1 Antibodies) and thus exerts anti-inflammatory and anti-proliferative effects on macrophages.
KLF5-dependent regulation of Myo9b (show MYO9B Antibodies)/RhoA (show RHOA Antibodies) is required for podosome formation and macrophage migration during abdominal aortic aneurysm.
Data show that R-Smad Proteins SMAD1 and SMAD5, which transduce bone morphogenetic protein (BMP) signals, recognize enhancer regions together with Kruppel-like factors KLF4 and KLF5 in naive embryonic stem cell (mESCs).
illustrates that KLF5 may modulate DNA repair pathways to prevent intestinal injury induced by TBI. KLF5 signaling provides a novel field for identification of potential therapeutic targets for the treatment of radiation-induced intestinal damage
Cardiac myocyte KLF5 is a transcriptional regulator of Ppara (show PPARA Antibodies) and cardiac energetics.
miR (show MLXIP Antibodies)-217 suppresses triple-negative breast cancer cell growth, migration, and invasion. MiR (show MLXIP Antibodies)-217 suppresses triple-negative breast cancer, at least partially, through down-regulating the KLF5 expression.
Data reveal that the presence of rs200996365, a SNP in high-linkage disequilibrium with rs8102137 residing in the center of a KLF5 motif, alters KLF5 binding to this genomic region and provide evidence that KLF5 binds CCNE1 (show CCNE1 Antibodies) polymorphic intronic enhancer to confer increased bladder cancer risk.
demonstrate that a 186bp region is the minimal essential region and that Sp3 (show SP3 Antibodies)-GC1 (show OLFM4 Antibodies) binding is essential to the basal expression of KLF5
We provide the first evidence that the expression of KLF5 is up-regulated in small airways and pulmonary vessels of patients with COPD (show ARCN1 Antibodies) and may be involved in the tissue remodeling of COPD (show ARCN1 Antibodies).
our results indicate that KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA (show VEGFA Antibodies) transcription
Data indicate direct binding of microRNA miR (show MLXIP Antibodies)-375 to the 3'-untranslated region of transcription factor KLF5.
findings collectively suggest that TNFAIP2 (show TNFAIP2 Antibodies) is a direct KLF5 target gene, and both KLF5 and TNFAIP2 (show TNFAIP2 Antibodies) promote breast cancer cell proliferation, migration and invasion through Rac1 and Cdc42 (show CDC42 Antibodies)
ABL (show ABL1 Antibodies)-N administration induced apoptosis of PC3 (show PCSK1 Antibodies) cells in a dose-dependent manner, along with the enhanced activity of caspases and increased Bax (show BAX Antibodies)/Bcl-2 (show BCL2 Antibodies) ratio. Expression of KLF5, Stat5b (show STAT5B Antibodies) and ICAM-1 (show ICAM1 Antibodies) was significantly downregulated in PC3 (show PCSK1 Antibodies) cells.
KLF5/Sox4 regulatory signaling play an important role in lung tumorigenesis, which might represent novel therapeutic targets to manage lung carcinoma.
BAP1 (show RNF2 Antibodies) interacts directly with KLF5 and stabilizes KLF5 via deubiquitination.
This gene encodes a member of the Kruppel-like factor subfamily of zinc finger proteins. Since the protein localizes to the nucleus and binds the epidermal growth factor response element, it is thought to be a transcription factor.
Kruppel-like factor 5 (intestinal)
, Krueppel-like factor 5-like
, Kruppel-like factor 5
, basic-transcription-element-binding-protein 2
, basic transcription element binding protein 2
, basic transcription element binding protein BTEB2
, BTE-binding protein 2
, Krueppel-like factor 5
, basic transcription element-binding protein 2
, intestinal-enriched krueppel-like factor
, transcription factor BTEB2
, GC box binding protein 2
, GC-box-binding protein 2
, colon krueppel-like factor
, colon kruppel-like factor
, intestinal-enriched kruppel-like factor